RESUMEN
Objectives: to evaluate the benefits of early streptokinase therapy in patients with acute myocardial infarction
Settings: district Headquarters and Allied Hospital, Faisalabad
Period: 1st January, 1997 to 30th May, 1997. Results: Out of 102 patients included in this study male to female ratio was 1.6 to 1.Forty seven percent received streptokinase therapy and 53% were denied due to any contraindication. The mean age was 52 years with 82.5% above the age of 40 years. 66.7% in both groups were in Killip Class-I, while 8.3% in streptokinase group and 3.7% in control group were in Killip Class-IV. The overall mortality was 17.6% but 29.8% in control group and only 4.2% in streptokinase group expired. The rhythm disturbances were more in streptokinase group. 66.7% presented late, and mechanical complications were more in the control group
Conclusion: the early streptokinase therapy lowers the in-hospital mortality but more public awareness is required for early reporting and efforts should be made for the availability of streptokinase for the poor community